These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

597 related items for PubMed ID: 8560901

  • 1. [Effectiveness, tolerance and safety of simvastatin in comparison with bezafibrate in treatment of hypercholesterolemia].
    Lechleitner M, Sailer S, Irsigler H, Klein W, Patsch JR.
    Wien Med Wochenschr; 1995; 145(21):577-83. PubMed ID: 8560901
    [Abstract] [Full Text] [Related]

  • 2. Comparison of the short term efficacy and tolerability of lovastatin and simvastatin in the management of primary hypercholesterolemia.
    Frohlich J, Brun LD, Blank D, Campeau L, Crockford P, Curnew G, Dafoe W, Davignon J, Dufour R, Emery G.
    Can J Cardiol; 1993 Jun; 9(5):405-12. PubMed ID: 8348392
    [Abstract] [Full Text] [Related]

  • 3. [The comparative treatment with lovastatin and bezafibrate of primary hypercholesterolemia. A randomized and double-blind trial].
    Sánchez Domínguez J, Rodríguez Padial L, Navarro A, Barcina C, Fernández E, Rivera G, Cuesta L, Lázaro-Carrasco E.
    Rev Esp Cardiol; 1991 Apr; 44(4):251-7. PubMed ID: 2068368
    [Abstract] [Full Text] [Related]

  • 4. A multicenter, randomized, double-blind, placebo-controlled, factorial design study to evaluate the lipid-altering efficacy and safety profile of the ezetimibe/simvastatin tablet compared with ezetimibe and simvastatin monotherapy in patients with primary hypercholesterolemia.
    Bays HE, Ose L, Fraser N, Tribble DL, Quinto K, Reyes R, Johnson-Levonas AO, Sapre A, Donahue SR, Ezetimibe Study Group.
    Clin Ther; 2004 Nov; 26(11):1758-73. PubMed ID: 15639688
    [Abstract] [Full Text] [Related]

  • 5. Comparison of the lipid-modifying efficacy and safety profiles of ezetimibe coadministered with simvastatin in older versus younger patients with primary hypercholesterolemia: a post Hoc analysis of subpopulations from three pooled clinical trials.
    Feldman T, Davidson M, Shah A, Maccubbin D, Meehan A, Zakson M, Tribble D, Veltri E, Mitchel Y.
    Clin Ther; 2006 Jun; 28(6):849-59. PubMed ID: 16860168
    [Abstract] [Full Text] [Related]

  • 6. Low-dose effect of simvastatin (MK-733) on serum lipids, lipoproteins, and apolipoproteins in patients with hypercholesterolemia.
    Saku K, Sasaki J, Arakawa K.
    Clin Ther; 1989 Jun; 11(2):247-57. PubMed ID: 2736571
    [Abstract] [Full Text] [Related]

  • 7. Treatment of primary hypercholesterolaemia with simvastatin. New Zealand multicentre evaluation.
    Lintott CJ, Scott RS, Sharpe DN, Nye ER, Charleson H, French JK, White HD, Reuben S, Maling TJ, Lewis GR.
    Med J Aust; 1991 Oct 07; 155(7):433-6. PubMed ID: 1921811
    [Abstract] [Full Text] [Related]

  • 8. Effects of rosuvastatin versus atorvastatin, simvastatin, and pravastatin on non-high-density lipoprotein cholesterol, apolipoproteins, and lipid ratios in patients with hypercholesterolemia: additional results from the STELLAR trial.
    Jones PH, Hunninghake DB, Ferdinand KC, Stein EA, Gold A, Caplan RJ, Blasetto JW, Statin Therapies for Elevated Lipid Levels Compared Across Doses to Rosuvastatin Study Group.
    Clin Ther; 2004 Sep 07; 26(9):1388-99. PubMed ID: 15531001
    [Abstract] [Full Text] [Related]

  • 9. [Comparison about the efficacy and tolerability between simvastatin and bezafibrate in the treatment of hypercholesterolemia].
    Bruckert E, Truffert J, De Gennes JL.
    Ann Med Interne (Paris); 1991 Sep 07; 142(7):505-10. PubMed ID: 1789528
    [Abstract] [Full Text] [Related]

  • 10. Simvastatin versus pravastatin: efficacy and tolerability in patients with primary hypercholesterolemia.
    Malini PL, Ambrosioni E, De Divitiis O, Di Somma S, Rosiello G, Trimarco B.
    Clin Ther; 1991 Sep 07; 13(4):500-10. PubMed ID: 1934003
    [Abstract] [Full Text] [Related]

  • 11. Combined bezafibrate and simvastatin treatment for mixed hyperlipidaemia.
    Kehely A, MacMahon M, Barbir M, Wray R, Hunt BJ, Prescott RJ, Thompson GR.
    QJM; 1995 Jun 07; 88(6):421-7. PubMed ID: 7648234
    [Abstract] [Full Text] [Related]

  • 12. Effects of ezetimibe/simvastatin on lipoprotein subfractions in patients with primary hypercholesterolemia: an exploratory analysis of archived samples using two commercially available techniques.
    Ose L, Reyes R, Johnson-Levonas AO, Sapre A, Tribble DL, Musliner T.
    Clin Ther; 2007 Nov 07; 29(11):2419-32. PubMed ID: 18158082
    [Abstract] [Full Text] [Related]

  • 13. A comparison of simvastatin and atorvastatin up to maximal recommended doses in a large multicenter randomized clinical trial.
    Illingworth DR, Crouse JR, Hunninghake DB, Davidson MH, Escobar ID, Stalenhoef AF, Paragh G, Ma PT, Liu M, Melino MR, O'Grady L, Mercuri M, Mitchel YB, Simvastatin Atorvastatin HDL Study Group.
    Curr Med Res Opin; 2001 Nov 07; 17(1):43-50. PubMed ID: 11464446
    [Abstract] [Full Text] [Related]

  • 14. [Effectiveness and tolerability of simvastatin in subjects with primary hypercholesterolemia. Multicenter study].
    Finardi G, Perani G, Tramarin R, Ricciardi R, Falaschi F, Franco C.
    Clin Ter; 1993 Mar 07; 142(3):225-33. PubMed ID: 8482062
    [Abstract] [Full Text] [Related]

  • 15. Comparative efficacy and safety of micronized fenofibrate and simvastatin in patients with primary type IIa or IIb hyperlipidemia.
    Farnier M, Bonnefous F, Debbas N, Irvine A.
    Arch Intern Med; 1994 Feb 28; 154(4):441-9. PubMed ID: 8117177
    [Abstract] [Full Text] [Related]

  • 16. A 52-week, randomized, open-label, parallel-group comparison of the tolerability and effects of pitavastatin and atorvastatin on high-density lipoprotein cholesterol levels and glucose metabolism in Japanese patients with elevated levels of low-density lipoprotein cholesterol and glucose intolerance.
    Sasaki J, Ikeda Y, Kuribayashi T, Kajiwara K, Biro S, Yamamoto K, Ageta M, Kobori S, Saikawa T, Otonari T, Kono S.
    Clin Ther; 2008 Jun 28; 30(6):1089-101. PubMed ID: 18640465
    [Abstract] [Full Text] [Related]

  • 17. Efficacy and safety of ezetimibe co-administered with simvastatin compared with atorvastatin in adults with hypercholesterolemia.
    Ballantyne CM, Blazing MA, King TR, Brady WE, Palmisano J.
    Am J Cardiol; 2004 Jun 15; 93(12):1487-94. PubMed ID: 15194018
    [Abstract] [Full Text] [Related]

  • 18. Efficacy, safety and tolerability of lovastatin and bezafibrate retard in patients with hypercholesterolemia.
    Schumacher M, Eber B, Silberbauer K, Breier C, Stühlinger W, Schmidt P, Gaul G, Klein W.
    Acta Med Austriaca; 1992 Jun 15; 19(5):140-4. PubMed ID: 1298143
    [Abstract] [Full Text] [Related]

  • 19. Long-term safety and, tolerability profiles and lipid-modifying efficacy of ezetimibe coadministered with ongoing simvastatin treatment: a multicenter, randomized, double-blind, placebo-controlled, 48-week extension study.
    Masana L, Mata P, Gagné C, Sirah W, Cho M, Johnson-Levonas AO, Meehan A, Troxell JK, Gumbiner B, Ezetimibe Study Group.
    Clin Ther; 2005 Feb 15; 27(2):174-84. PubMed ID: 15811480
    [Abstract] [Full Text] [Related]

  • 20. Achieving lipoprotein goals in patients at high risk with severe hypercholesterolemia: efficacy and safety of ezetimibe co-administered with atorvastatin.
    Stein E, Stender S, Mata P, Sager P, Ponsonnet D, Melani L, Lipka L, Suresh R, Maccubbin D, Veltri E, Ezetimibe Study Group.
    Am Heart J; 2004 Sep 15; 148(3):447-55. PubMed ID: 15389231
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 30.